A global technology company was separating its hardware and software divisions into two independent business units. IP was deeply integrated across both, and the company needed…
A multinational manufacturer held more than 250 patents in industrial automation. Many were used in core products, but a significant portion remained under-used.
A major ASX-listed resources company was negotiating a licence for its IP relating to a novel carbon capture technology.
A mid-cap ASX-listed biotech had completed Phase I clinical trials and was preparing a global roadshow to explore acquisition or licensing opportunities.
A US-domiciled multinational mining company was negotiating a joint venture with a small-cap Australian miner to develop a new metals processing technology.